Neurosense Therapeutics Ltd (NRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,349 | 8,735 | N/A | 0 | 699 |
| Marketable Securities | 6,048 | 5,068 | N/A | 0 | 37 |
| Receivables | 707 | 225 | N/A | 0 | 30 |
| TOTAL | $11,104 | $14,028 | $N/A | $0 | $766 |
| Non-Current Assets | |||||
| PPE Net | 46 | 42 | N/A | N/A | 16 |
| Investments And Advances | 35 | 0 | 0 | 0 | 37 |
| Other Non-Current Assets | 268 | 287 | 0 | 0 | 0 |
| TOTAL | $349 | $329 | $N/A | $N/A | $53 |
| Total Assets | $11,453 | $14,357 | $N/A | $0 | $779 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 736 | 1,228 | 0 | 0 | 55 |
| Other current liabilities | N/A | N/A | N/A | 0 | 65 |
| TOTAL | $736 | $1,228 | $N/A | $0 | $120 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 691 | 816 | 0 | 0 | 0 |
| TOTAL | $881 | $1,023 | $N/A | $N/A | $N/A |
| Total Liabilities | $1,617 | $2,251 | $N/A | $0 | $120 |
| Shareholders' Equity | |||||
| Retained earnings | -14,642 | -11,161 | N/A | 0 | -4,405 |
| TOTAL | $9,836 | $12,106 | $N/A | $0 | $659 |
| Total Liabilities And Equity | $11,453 | $14,357 | $0 | $0 | $779 |